Home
Dipna Pharmachem Ltd Share Price History

Dipna Pharmachem Ltd
BSE : 14 Aug, 2025
19.13-0.9 (-4.4%)
Prev Close
20.0
Open Price
19.1
Bid Price (QTY)
-
Offer Price (QTY)
-
Volume
12000
Today's High / Low
19.1 / 19.1
52 WK High / Low
26.3 / 6.4
Market Price of Dipna Pharmachem Ltd
1M
1Y
3Y
5Y
Monitoring Dipna Pharmachem Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.
History Market Price
Date | Price | Open | High | Low |
---|
Returns Comparison
1W
1M
3M
6M
1Y
3Y
5Y
10Y
Growth Parameters
Parameter | |
---|---|
Sales (Cr.) | 17 |
Sales YoY Gr. | - |
Adj EPS | 17.27 |
YoY Gr. | - |
Net Profit (Cr.) | 0 |
BVPS | 130.4 |
Key Financial Parameters
Parameter | |
---|---|
Return on Capital Emp. % | 7.19 |
Op. Profit Mgn % | 2.42 |
Net Profit Mgn % | 0.36 |
Debt to Equity % | 11.09 |
Latest Shareholding
Promoters Holdings Over Time
About Dipna Pharmachem Ltd
- Dipan Pharmachem Private Limited was incorporated on July 19, 2011.
- Subsequently, the Company name was changed to 'Dipna Pharmachem Private Limited' on March 29, 2012.
- Later on, it was converted from Private Limited to Public Limited and the name of Company was changed to 'Dipna Pharmachem Limited' vide fresh Certificate of Incorporation issued by Registrar of Companies, Ahmedabad dated May 25, 2022. Mr. Keyur Shah, being the Promoter, the Company is engaged in trading and distribution of pharmaceutical raw material and chemical formulation products, also known as APIs (Active Pharmaceutical Ingredients).
- Presently, its product portfolio comprises of 61 AIPs and AIPs intermediates such as Cephalosporins, Cardiovasculars, Anti - Bactaria, Quinolones, Veterinary, Anti - Virus, Anti - Inflammatory, Neuropsychiatry, Steroid Hormone, other etc.
Popular Search
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.